Search

Your search keyword '"Harms, Matthew B."' showing total 258 results

Search Constraints

Start Over You searched for: Author "Harms, Matthew B." Remove constraint Author: "Harms, Matthew B."
258 results on '"Harms, Matthew B."'

Search Results

2. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

3. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

4. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial

5. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

6. High-impact rare genetic variants in severe schizophrenia

7. The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

8. The Answer ALS return of results study: Answering the duty to disclose.

10. Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.

11. Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS

14. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

15. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

16. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy

17. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

18. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

19. Clinical testing panels for ALS : global distribution, consistency, and challenges

20. Evidence‐based consensus guidelines for ALS genetic testing and counseling.

23. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

24. Clinical testing panels for ALS: global distribution, consistency, and challenges

27. Genotype-phenotype correlations in valosin-containing protein disease

28. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

36. The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

37. ALS GENES: Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

39. Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders

40. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

41. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

42. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

45. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

49. Dominant mutations in ITPR3 cause Charcot‐Marie‐Tooth disease

Catalog

Books, media, physical & digital resources